Although JARID1C’s oncogenic versus tumor suppressive effects vary with cancer type [11–14], JARID1A and JARID1B primarily have tumor-promoting functions and are amplified in some malignancies [4, 9, 15, 16]. This evidence concerns the gene KDM5C and cancer.